Toll样受体7在动脉粥样硬化中的研究进展
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

广东省科技计划项目(2009B3060700010)及广东省佛山市科技发展专项(2009025,2011AA100473)


Research Advancement of Toll-like Receptor 7 in Atherosclerosis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    Toll样受体7(toll-like receptor-7,TLR7)是表达于哺乳动物细胞内的Ⅰ型跨膜蛋白受体,具有与其他TLR家族成员共同的结构特征及相似功能。TLR7除了可通过MyD88信号依赖型通路调节病毒诱导的相关免疫反应外,也可调节巨噬细胞的自噬从而介导动脉粥样硬化的进展;各种配体及内源性分子,不仅可通过诱导Ⅰ型干扰素表达,也可作为自身抗原,激活T细胞、B细胞所介导的细胞、体液免疫反应,从而参与调控动脉粥样硬化的发生发展。因此,对于TLR7在动脉粥样硬化的作用及机制研究必将是动脉粥样硬化防治一个重要的新起点。

    Abstract:

    Toll-like receptor 7 (TLR7),a type Ⅰ transmembrane protein receptor expressed in mammalian cells,has the same structure characters and similar functions as other members of TLR family.In addition to regulating some immune responses induced by virus through the MyD88-dependent signaling pathway,TLR7 can adjust the autophagy of macrophages to mediate the progress of atherosclerosis.Furthermore,it is probably to not only induce the type Ⅰ interferon expression,but also act as autoantigens to activate cellular and humoral immune response mediated by T cells and B cells by all kinds of ligand and endogenous molecules,thus participate in regulating the development of atherosclerosis.Therefore,it is critical that more attention is given to the function and mechanism research of TLR7 in atherosclerosis,which will be a new starting point for the prevention and control of atherosclerosis.

    参考文献
    相似文献
    引证文献
引用本文

黄伟俊 综述,黄裕立,胡允兆 审校. Toll样受体7在动脉粥样硬化中的研究进展[J].中国动脉硬化杂志,2015,23(07):740~743.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2014-06-16
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2015-07-03